Retatrutide

Investigational triple receptor agonist targeting GIP, GLP-1 and glucagon pathways in metabolic research. Available formats: 5mg x 10vials • 10mg x 10vials • 15mg x 10vials +7 more Temporary catalog price. Contact for current pricing and availability. Reference listing: Verify identity, analytical documentation and jurisdictional status before use. For professional product-reference and cataloging purposes. Not medical advice or a statement of therapeutic efficacy.